Michael Ryskin
Stock Analyst at Bank of America Securities
(3.26)
# 2,461
Out of 4,399 analysts
667
Total ratings
50.4%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintained: Buy | n/a | $186.29 | - | 19 | Jun 5, 2026 | |
| ZTS Zoetis | Maintained: Hold | $140 → $108 | $81.29 | +32.86% | 42 | Jun 5, 2026 | |
| PAHC Phibro Animal Health | Maintained: Sell | $38 | $31.18 | +21.87% | 14 | Jun 5, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | $30 → $32 | $22.87 | +39.92% | 35 | Jun 5, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $145 → $155 | $131.62 | +17.76% | 24 | Jun 2, 2026 | |
| BRKR Bruker | Reiterated: Buy | $65 | $54.92 | +18.35% | 25 | Jun 2, 2026 | |
| DHR Danaher | Maintained: Buy | $270 | $183.63 | +47.03% | 38 | Jun 2, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $630 | $482.04 | +30.69% | 29 | Jun 2, 2026 | |
| WAT Waters | Reiterated: Hold | $370 → $400 | $363.18 | +10.14% | 20 | Jun 2, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | n/a | $330.92 | - | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $105 → $125 | $144.59 | -13.55% | 20 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 | $49.48 | +29.35% | 15 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $175 | $170.50 | +2.64% | 24 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 | $162.47 | -38.45% | 46 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $101.29 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $29.11 | - | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $37.02 | +32.36% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 | $182.17 | +34.49% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $17.16 | +63.17% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $27 | $21.51 | +25.52% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,133.03 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $4.43 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.61 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $135 | $130.70 | +3.29% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.15 | - | 22 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $9.5 | $16.34 | -41.86% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $790 → $660 | $556.94 | +18.50% | 31 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $11 | $11.28 | -2.48% | 13 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $203.78 | +10.41% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $295 | $268.63 | +9.82% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $28 | $17.25 | +62.32% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $9.65 | +13.99% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $5.08 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $5.18 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $7.94 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $6.38 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.04 | n/a | 2 | Apr 18, 2022 |
Charles River Laboratories International
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $186.29
Upside: -
Zoetis
Jun 5, 2026
Maintained: Hold
Price Target: $140 → $108
Current: $81.29
Upside: +32.86%
Phibro Animal Health
Jun 5, 2026
Maintained: Sell
Price Target: $38
Current: $31.18
Upside: +21.87%
Elanco Animal Health
Jun 5, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $22.87
Upside: +39.92%
Agilent Technologies
Jun 2, 2026
Reiterated: Buy
Price Target: $145 → $155
Current: $131.62
Upside: +17.76%
Bruker
Jun 2, 2026
Reiterated: Buy
Price Target: $65
Current: $54.92
Upside: +18.35%
Danaher
Jun 2, 2026
Maintained: Buy
Price Target: $270
Current: $183.63
Upside: +47.03%
Thermo Fisher Scientific
Jun 2, 2026
Maintained: Buy
Price Target: $630
Current: $482.04
Upside: +30.69%
Waters
Jun 2, 2026
Reiterated: Hold
Price Target: $370 → $400
Current: $363.18
Upside: +10.14%
West Pharmaceutical Services
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $330.92
Upside: -
Jun 1, 2026
Reiterated: Sell
Price Target: $105 → $125
Current: $144.59
Upside: -13.55%
Jun 1, 2026
Maintained: Hold
Price Target: $64
Current: $49.48
Upside: +29.35%
May 27, 2026
Maintained: Sell
Price Target: $175
Current: $170.50
Upside: +2.64%
May 14, 2026
Maintained: Sell
Price Target: $100
Current: $162.47
Upside: -38.45%
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $101.29
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $29.11
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $37.02
Upside: +32.36%
May 13, 2026
Maintained: Buy
Price Target: $245
Current: $182.17
Upside: +34.49%
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $17.16
Upside: +63.17%
May 12, 2026
Initiated Coverage: Hold
Price Target: $27
Current: $21.51
Upside: +25.52%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1,133.03
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $4.43
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $2.61
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $120 → $135
Current: $130.70
Upside: +3.29%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $14.15
Upside: -
May 6, 2026
Reiterated: Sell
Price Target: $8 → $9.5
Current: $16.34
Upside: -41.86%
May 5, 2026
Maintained: Hold
Price Target: $790 → $660
Current: $556.94
Upside: +18.50%
Apr 29, 2026
Maintained: Hold
Price Target: $13 → $11
Current: $11.28
Upside: -2.48%
Apr 21, 2026
Maintained: Buy
Price Target: $225
Current: $203.78
Upside: +10.41%
Apr 7, 2026
Maintained: Buy
Price Target: $295
Current: $268.63
Upside: +9.82%
Mar 4, 2026
Maintained: Buy
Price Target: $30 → $28
Current: $17.25
Upside: +62.32%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $9.65
Upside: +13.99%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $5.08
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $5.18
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $7.94
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $6.38
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.04
Upside: n/a